The Patents Bill was introduced in 2005.
Much of the mainstream press has emphasized a business perspective when reporting this development, focusing on India's opportunity to tap the Western generic drug market while only briefly acknowledging the potentially devastating impact of the new rule on vulnerable populations.From here. Two people - Sandeep Junnarkar and Srinivas Kuruganti plan to
... create a baseline record that establishes how India's HIV-infected populations depend on the Indian versions of Western patented Anti-retro Viral (ARV) drugs to survive.
No comments:
Post a Comment